Gastric and intestinal phenotypic correlation between exocrine and endocrine components in human stomach tumors

Histology and Histopathology

Volumn 22, Issue 1-3, 2007, Pages 273-284

  Takenaka, Y ^a,b   Tsukamoto, Tetsuya ^a   Mizoshita, T ^a   Ogasawara, N ^a   Hirano, N ^a   Otsuka, T ^a   Ban, H ^a   Nakamura, T ^a   Yamamura, Y ^a   Kaminishi, M ^b   Tatematsu, M ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer stem cells; Endocrine cell; Phenotypes; Progenitor cell; Stomach cancers

Indexed keywords

BIOLOGICAL MARKER; CHROMOGRANIN A;

ADENOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STEM CELL; CARCINOID; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOCRINE CELL; EXOCRINE CELL; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN LOCALIZATION; STOMACH CANCER;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; CARCINOID TUMOR; CELL COUNT; CHROMOGRANIN A; ENDOCRINE GLANDS; EXOCRINE GLANDS; FEMALE; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PHENOTYPE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846315444     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J. and Clarke M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988.
2. Bamba M., Sugihara H., Kushima R., Okada K., Tsukashita S., Horinouchi M. and Hattori T. (2001). Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach. Virchows Arch. 438, 49-56.
3. Blumenfeld W., Chandhoke D.K., Sagerman P. and Turi G.K. (1996). Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study. Arch. Pathol. Lab. Med. 120, 478-481.
4. Bonnet D. and Dick J.E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737.
5. Bordi C., Yu J.Y., Baggi M.T., Davoli C., Pilato F.P., Baruzzi G., Gardini G., Zamboni G., Franzin G., Papotti M. and Bussolati G. (1991). Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 67, 663-672.
6. Egashira Y., Shimoda T. and Ikegami M. (1999). Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol. Int. 49, 55-61.
7. Endoh Y., Sakata K., Tamura G., Ohmura K., Ajioka Y., Watanabe H. and Motoyama T. (2000). Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J. Pathol. 191, 257-263.
8. Hattori T. (1986). Development of adenocarcinomas in the stomach. Cancer 57, 1528-1534.
9. Hirohashi S. and Sugimura T. (1991). Genetic alterations in human gastric cancer. Cancer Cells 3, 49-52.
10. Japanese Gastric Cancer Association (1998). Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1, 10-24.
11. Kawachi H., Takizawa T., Eishi Y., Shimizu S., Kumagai J., Funata N. and Koike M. (2003). Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. J. Pathol. 199, 436-446.
12. Kushima R. and Hattori T. (1993). Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J. Cancer Res. Clin. Oncol. 120, 103-111.
13. La Rosa S., Rigoli E., Uccella S., Chiaravalli A.M. and Capella C. (2004). CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors. Virchows Arch. 445, 248-254.
14. Lauren P. (1965). The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64, 31-49.
15. Mizoshita T., Inada K., Tsukamoto T., Kodera Y., Yamamura Y., Hirai T., Kato T., Joh T., Itoh M. and Tatematsu M. (2001). Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa--with special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 4, 185-191.
16. Mizoshita T., Tsukamoto T., Nakanishi H., Inada K., Ogasawara N., Joh T., Itoh M., Yamamura Y. and Tatematsu M. (2003). Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J. Cancer Res. Clin. Oncol. 129, 727-734.
17. Mizoshita T., Inada K., Tsukamoto T., Nozaki K., Joh T., Itoh M., Yamamura Y., Ushijima T., Nakamura S. and Tatematsu M. (2004a). Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J. Cancer Res. Clin. Oncol. 130, 29-36.
18. Mizoshita T., Tsukamoto T., Inada K., Ogasawara N., Hirata A., Kato S., Joh T., Itoh M., Yamamura Y. and Tatematsu M. (2004b). Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol. Int. 54, 392-400.
19. Mizoshita T., Tsukamoto T., Cao X., Otsuka T., Ito S., Takahashi E., Nakamura S., Nakamura T., Yamamura Y. and Tatematsu M. (2005). Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotype. Gastric Cancer 8, 164-172.
20. Nakamura K., Sugano H. and Takagi K. (1968). Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 59, 251-258.
21. Naritomi K., Futami K., Arima S. and Iwashita A. (2003). Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma. Anticancer Res. 23, 4411-4422.
22. Nishikura K., Watanabe H., Iwafuchi M., Ajioka Y., Hashidate H. and Tanabe T. (2000). Histological overview of the classification of gastric carcinoid. Stomach Intestine 35, 1349-1354. (in Japanese with English summary).
23. Nishikura K., Watanabe H., Iwafuchi M., Fujiwara T., Kojima K. and Ajioka Y. (2003). Carcinogenesis of gastric endocrine cell carcinoma: analysis of histopathology and p53 gene alteration. Gastric Cancer 6, 203-209.
24. Ogasawara S., Maesawa C., Tamura G. and Satodate R. (1994). Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas. Virchows Arch. 424, 607-611.
25. Otsuka T., Tsukamoto T., Mizoshita T., Inada K., Takenaka Y., Kato S., Yamamura Y., Miki K. and Tatematsu M. (2005). Coexistence of gastric- and intestinal-type endocrine cells in gastric and intestinal mixed intestinal metaplasia of the human stomach. Pathol. Int. 55, 170-179.
26. Park J.G., Choe G.Y., Helman L.J., Gazdar A.F., Yang H.K., Kim J.P., Park S.H. and Kim Y.I. (1992). Chromogranin-A expression in gastric and colon cancer tissues. Int. J. Cancer 51, 189-194.
27. Qvigstad G., Sandvik A.K., Brenna E., Aase S. and Waldum H.L. (2000). Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique. Histochem. J. 32, 551-556.
28. Sakurai S., Sano T., Maeshima A., Kashiwabara K., Oyama T., Fukuda T. and Nakajima T. (1995). Gastric adenoma-carcinoma sequence with special reference to p53 and Ki-ras gene alterations. Virchows Arch. 427, 119-124.
29. Schier S. and Wright N.A. (2005). Stem cell relationships and the origin of gastrointestinal cancer. Oncology 69 Suppl 1, 9-13.
30. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D. and Dirks P.B. (2004). Identification of human brain tumour initiating cells. Nature 432, 396-401.
31. Sugano H., Nakamura K. and Kato Y. (1982). Pathological studies of human gastric cancer. Acta Pathol. Jpn. 32 (Suppl 2), 329-347.
32. Tahara E. and Yokozaki H. (1996). The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J. Pathol. 178, 475-476.
33. Tahara E., Haizuka S., Kodama T. and Yamada A. (1975). The relationship of gastrointestinal endocrine cells to gastric epithelial changes with special reference to gastric cancer. Acta Pathol. Jpn. 25, 161-177.
34. Tamura G., Sakata K., Maesawa C., Suzuki Y., Terashima M., Satoh K., Sekiyama S., Suzuki A., Eda Y. and Satodate R. (1995). Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res. 55, 1933-1936.
35. Tatematsu M., Ichinose M., Miki K., Hasegawa R., Kato T. and Ito N. (1990). Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol. Jpn. 40, 494-504.
36. Tatematsu M., Fukami H., Yamamoto M., Nakanishi H., Masui T., Kusakabe N. and Sakakura T. (1994). Clonal analysis of glandular stomach carcinogenesis in C3H/HeN<==>BALB/c chimeric mice treated with N-methyl-N-nitrosourea. Cancer Lett. 83, 37-42.
37. Tatematsu M., Masui T., Fukami H., Yamamoto M., Nakanishi H., Inada K., Kusakabe M. and Sakakura T. (1996). Primary monoclonal and secondary polyclonal growth of colon neoplastic lesions in C3H/HeN<-->BALB/c chimeric mice treated with 1,2-dimethylhydrazine immunohistochemical detection of C3H strain-specific antigen and simple sequence length polymorphism analysis of DNA. Int. J. Cancer 66, 234-238.
38. Tatematsu M., Tsukamoto T. and Inada K. (2003). Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci. 94, 135-141.
39. Tatematsu M., Tsukamoto T. and Mizoshita T. (2005). Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter 10, 97-106.
40. Tsukamoto T., Inada K., Tanaka H., Mizoshita T., Mihara M., Ushijima T., Yamamura Y., Nakamura S. and Tatematsu M. (2004). Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J. Cancer Res. Clin. Oncol. 130, 135-145.
41. Tsukamoto T., Mizoshita T., Mihara M., Tanaka H., Takenaka Y., Yamamura Y., Nakamura S., Ushijima T. and Tatematsu M. (2005). Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 46, 649-658.
42. Tsukamoto T., Yamamoto M., Fukami H., Yoshikawa A., Sakai H., Hirata A., Kusakabe M. and Tatematsu M. (2006). Susceptibility to colon carcinogenesis in C3H <-> C57BL/6 chimeric mice reflects both tissue microenvironment and genotype. Cancer Lett. (in press).
43. Tzaneva M.A. (2002). Endocrine cells in gastric carcinoma and adjacent mucosa. An immunohistochemical and ultrastructural study. Histochem. J. 34, 173-180.
44. Waldum H.L., Aase S., Kvetnoi I., Brenna E., Sandvik A.K., Syversen U., Johnsen G., Vatten L. and Polak J.M. (1998). Neuroendocrine differentiation in human gastric carcinoma. Cancer 83, 435-444.
45. Yamachika T., Inada K., Fujimitsu Y., Nakamura S., Yamamura Y., Kitou T., Itzkowitz S.H., Werther J.L., Miki K. and Tatematsu M. (1997). Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch. 431, 103-110.
46. Yoshikawa A., Inada Ki K., Yamachika T., Shimizu N., Kaminishi M. and Tatematsu M. (1998). Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1, 134-141.